On ECHEMI
Home > Drugs > Jiangxi Conba Traditional Chinese MEDICINE Co., Ltd.
Jiangxi Conba Traditional Chinese MEDICINE Co., Ltd.
  • Founded in:

    2008-07-15
  • Country:

    China China
  • Address:

    No. 1, Zhanwang Road, High-tech Park, Yiyang County, Shangrao City, Jiangxi Province
  • Tax NO.:

    91361126677950534F
  • Registered Funds:

    170 million yuan
  • Email:

Related Drugs
Racemic Anisodamine Tablets
The main ingredient of this product is racemic anisodamine. Its chemical name is (±)-6β-hydroxy-1aH, 5aH-tropane-3a-ol tropate.
Name Description Content CAS NO. Registered Holders
Anisodamine

This product is an anticholinergic drug that can significantly relieve gastrointestinal smooth muscle spasm.

More

This product is an anticholinergic drug that can significantly relieve gastrointestinal smooth muscle spasm.

17659-49-3 6
Ribavirin Tablets
Ribavirin
Name Description Content CAS NO. Registered Holders
Ribavirin

Broad-spectrum antiviral drug. It has the effect of inhibiting the growth of multiple viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro, and its mechanism is not fully understood. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.

More

Broad-spectrum antiviral drug. It has the effect of inhibiting the growth of multiple viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro, and its mechanism is not fully understood. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.

36791-04-5 33
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.